Zevra Therapeutics (ZVRA) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Zevra Therapeutics (ZVRA) Net Income towards Common Stockholders (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Zevra Therapeutics |
787.90 Mn |
587.28 Mn |
34.30 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
211.47% |
| Dec 31, 2025 |
2,336.21% |
| Sep 30, 2025 |
-100.73% |
| Jun 30, 2025 |
2,510.68% |
| Mar 31, 2025 |
91.33% |
| Dec 31, 2024 |
-7.57% |
| Sep 30, 2024 |
-66.75% |
| Jun 30, 2024 |
-19.87% |
| Mar 31, 2024 |
16.44% |
| Dec 31, 2023 |
-91.88% |
| Sep 30, 2023 |
-302.91% |
| Jun 30, 2023 |
78.13% |
| Mar 31, 2023 |
-30.44% |
| Dec 31, 2022 |
-36.35% |
| Sep 30, 2022 |
72.48% |
| Jun 30, 2022 |
-1,189.81% |
| Mar 31, 2022 |
31.04% |
| Dec 31, 2021 |
-53.67% |
| Sep 30, 2021 |
83.55% |
| Jun 30, 2021 |
77.60% |
